Roni Tamari, MD

Trials

Studies that name Roni Tamari, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:51 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT06903702 · A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia

  Memorial Sloan Kettering Cancer Center · withdrawn · Acute Myeloid Leukemia · principal investigator
• Ph1
  NCT03531736 · T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia

  Memorial Sloan Kettering Cancer Center · active not recruiting · Myeloid Diseases · principal investigator
• N/A
  NCT02677064 · Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

  Memorial Sloan Kettering Cancer Center · recruiting · Acute Leukemia, Newly Diagnosed, Relapsed · principal investigator
• Ph2
  NCT02350777 · T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation

  Memorial Sloan Kettering Cancer Center · terminated · Hematopoietic Stem Cell Transplant, Poor Marrow Graft Function · principal investigator
• Ph1
  NCT02193191 · Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease

  Memorial Sloan Kettering Cancer Center · completed · Sickle Cell Disease · principal investigator
• Ph2
  NCT01995578 · Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse

  Memorial Sloan Kettering Cancer Center · completed · Myelodysplastic Syndromes (MDS), Acute Myelogenous Leukemia (AML) · principal investigator
• Ph2
  NCT00629798 · Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

  Memorial Sloan Kettering Cancer Center · completed · Acute Myeloid Leukemia, Advanced Myelodysplastic Syndromes · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.